KRT19 and hepatocellular carcinoma: The results demonstrated that high expression of CK19 (KRT19), Ki67 (MKI67), and β-catenin (CTNNB1) was negatively correlated with overall survival (OS) in HCC patients, with higher expression levels corresponding to lower survival rates (Fig. 2).